Laboratory & Science Research

Our Mission

Harnessing the power of plant enzymes to discover new and improved existing anti-cancer drugs…delivering better care for patients

0 +

Years Experienced

0 +

Papers

0

Potential Compounds

Who We Are

Ophelos Therapeutics

Ophelos Therapeutics is led by pioneers in innovation of biomedical products and services, supported by a seasoned pharma management team and respected scientific research team.

  • Our disruptive technology was formed with a vision of rapidly commercializing proprietary pharmaceutical discoveries and technologies
  • We utilize an innovative AI-driven drug rescue/improvement platform that can modify drugs trapped in the development pipeline due to toxicity, and low efficacy
  • By employing a proprietary method and process of enzyme glycosylation we can discover novel derivatives of new or approved drugs, with far more desirable pharmacological properties; increasing the clients patent portfolio
  • As a result, instead of administering a drug directly, a corresponding prodrug can be used to improve how the drug is absorbed, distributed, metabolised, and excreted (ADME)

What’s New In The Field And Our Labs

More Articles

Copyright © 2022 Ophelos Therapeautics, All rights reserved.